Gene · 8192
Papers2,606
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,606
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ONC201/dordaviprone for H3 K27M-mutant tumors: Discovery, mechanisms, therapeutic potential, and future directions. | Genes Dis | 2027 | 42751161 | PubTator, text mining | PubMed |
| Development of High-Efficiency Mitochondrial Protease Targeting Chimeras (MtPTACs) for Targeted Degradation of POLRMT and Beyond. | JACS Au | 2026 | 42819300 | PubTator, text mining | PubMed |
| Targeting ClpP Rewires the Metabolic-Immune Axis in Acute Myeloid Leukemia. | Cancer Res | 2026 | 42804164 | PubTator, text mining | PubMed |
| CLPP loss confers sex-specific protection from renal ischemia reperfusion injury. | Redox Biol | 2026 | 42800460 | PubTator, text mining | PubMed |
| Mitochondrial CLPP in Health and Disease: Mechanisms, Therapeutic Duality and Emerging Opportunities. | J Inherit Metab Dis | 2026 | 42687680 | PubTator, text mining | PubMed |
| Metformin activates the mitochondrial unfolded protein response via the AMPK/SIRT1 pathway to delay intervertebral disc degeneration. | Free Radic Biol Med | 2026 | 42685933 | PubTator, text mining | PubMed |
| Design, Synthesis, and Structure-Activity Relationships of Novel Piperidine-Fused Imidazolone ClpP Activators as Potential Anti-Cancer Agents. | Molecules | 2026 | 42653996 | PubTator, text mining | PubMed |
| Plastome convergence across endoparasitic plant lineages: genome reduction, high AT bias, elevated substitution rates, and functional persistence in Mitrastemon yamamotoi. | Ann Bot | 2026 | 42548282 | PubTator, text mining | PubMed |
| An adaptor for feedback regulation of heme biosynthesis by a mitochondrial protease. | Science | 2026 | 42531414 | PubTator, text mining | PubMed |
| Interplay of Epigenetic Reprogramming, Mitochondrial Metabolism, and Dopamine Signalling Pathways Uncovers Metabolic Vulnerabilities in Diffuse Midline Glioma. | Cancers (Basel) | 2026 | 42512251 | PubTator, text mining | PubMed |
| Demonstrating Fluorescent Peptidyl Inhibitor Targeting of Mitochondrial ClpXP by Fluorescence Microscopy in Mammalian Cells. | J Vis Exp | 2026 | 42507655 | PubTator, text mining | PubMed |
| Comparative plastome analysis and plastomic phylogeny of Moraceae with expanded species-level sampling. | BMC Plant Biol | 2026 | 42458251 | PubTator, text mining | PubMed |
| Mitochondrial Dysfunction in Ulcerative Colitis: Pathogenic Mechanisms and Novel Therapeutics. | J Biochem Mol Toxicol | 2026 | 42455958 | PubTator, text mining | PubMed |
| Targeting mitochondrial protease in diffuse gliomas. | Mol Cancer Ther | 2026 | 42442344 | PubTator, text mining | PubMed |
| Dysregulation of Human ClpP Using Small Molecules with Piperazine-Based Scaffold for Diffuse Intrinsic Pontine Glioma Therapy Validated by Patient-Derived Tumor Organoids. | J Med Chem | 2026 | 42418817 | PubTator, text mining | PubMed |
| ClpP deficiency attenuates contrast-induced HK-2 cell injury through changes associated with mitochondrial dynamics and apoptosis. | PLoS One | 2026 | 42391150 | PubTator, text mining | PubMed |
| Phylogenomics, divergence time estimation, and biogeography of Iris species from Kazakhstan using plastome sequence analysis. | Front Plant Sci | 2026 | 42389122 | PubTator, text mining | PubMed |
| Chloroplast Phylogenomics and Evolutionary History of the Alpine Endemic Eutrema scapiflorum. | Int J Mol Sci | 2026 | 42352919 | PubTator, text mining | PubMed |
| Comprehensive Insights into Perrault Syndrome: Genetic Diversity and Clinical Implications. | Reprod Sci | 2026 | 42283975 | PubTator, text mining | PubMed |
| CLPX acquires an iron-sulfur cluster to sustain mitochondrial proteostasis in cancer cells. | Nat Commun | 2026 | 42265110 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8192/papers